Eudaimonia Partners, LLC Northwest Biotherapeutics Inc Transaction History
Eudaimonia Partners, LLC
- $416 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding NWBO
# of Institutions
15Shares Held
688KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC424KShares$135,7790.03% of portfolio
-
Opus Capital Group, LLC60.2KShares$19,2480.0% of portfolio
-
Maripau Wealth Management LLC Fort Wayne, IN39.5KShares$12,6370.01% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$11,2000.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$7,5840.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $332M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...